Dama, Azzubayn A.
HRN: 21-45-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/13/2022
06/20/2022
IV DRIP
250mg
Q6H
Sepsis, Abscess Right Mastoid Area
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes